Cyamopsis Biotech (India) Private Limited, a active private limited company, was established on 14 March 2012 in Sirsa, Haryana, India. Engaging in specialty chemicals within the trade sector, it holds CIN: U01136HR2012PTC045395. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹7.30 Cr and a paid-up capital of ₹7.26 Cr.
Formerly known as Dada Ganpati Guar Products Private Limited. It upholds a compliant status. Employing 4 professional, Its leadership includes Anju Jalan (Director), Suresh Kumar Singla (Director), Raj Kumar Jalan (Director). It holds ₹30.25 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 12Th Km Stone, Hisar Road, Village- Moriwala, Sirsa, Haryana, 125060.
U01136HR2012PTC045395
045395
14 March 2012
₹7.30 Cr
₹7.26 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Cyamopsis Biotech (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anju Jalan | Director | 14 Mar 2012 | Current |
| Suresh Kumar Singla | Director | 14 Mar 2012 | Current |
| Raj Kumar Jalan | Director | 14 Mar 2012 | Current |
| Pankaj Khemka | Director | 14 Mar 2012 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cyamopsis Biotech (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.11% increase. The company also saw a substantial improvement in profitability, with a 118.12% increase in profit. The company's net worth moved up by a moderate rise of 5.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Cyamopsis Biotech (India) had a promoter holding of 49.23% and a public holding of 50.77%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹302,480,999.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jul 2024 | Others | ₹15.00 Cr | Open |
| 16 May 2024 | Axis Bank Limited | ₹1.68 Cr | Open |
| 05 Apr 2024 | Axis Bank Limited | ₹1.00 M | Open |
| 26 Sep 2023 | Hdfc Bank Limited | ₹1.98 M | Open |
| 29 Nov 2012 | State Bank Of India | ₹13.27 Cr | Open |
Explore comprehensive loan charge details -
Cyamopsis Biotech (India) has a workforce of 4 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cyamopsis Biotech (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cyamopsis Biotech (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 15.00 Cr registered on 27 Jul 2024 with Charge ID 100961112 was modified on 16 Oct 2024. was recorded as a recent event.
Cyamopsis Biotech (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 15.00 Cr with Charge ID 100961112 was registered on 27 Jul 2024. was completed.
A charge with Axis Bank Limited amounted to Rs. 1.68 Cr with Charge ID 100921536 was registered on 16 May 2024. was recorded as a recent event.
Progress on A charge with Axis Bank Limited amounted to Rs. 0.10 Cr with Charge ID 100917906 was registered on 05 Apr 2024. was documented.
Cyamopsis Biotech (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The CIN of Cyamopsis Biotech (India) Private Limited is U01136HR2012PTC045395.
Cyamopsis Biotech (India) Private Limited is headquartered at 12Th Km Stone, Hisar Road, Village- Moriwala, Sirsa, Haryana, 125060.
Cyamopsis Biotech (India) Private Limited was incorporated on 14 March 2012.
The current directors of Cyamopsis Biotech (India) Private Limited are
The primary industry of Cyamopsis Biotech (India) Private Limited is Trade.
Cyamopsis Biotech (India) Private Limited is unlisted.
The authorized capital of Cyamopsis Biotech (India) Private Limited is ₹7.30 Cr, and the paid-up capital is ₹7.26 Cr.
The compliance status of Cyamopsis Biotech (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
_PRIVATE_LIMITED_383653.webp)
Company Details
+91-XXXXXXXXXX